Clinical Trial Update: High and Low Dose Carbidopa Treatment of Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating high and low dose carbidopa treatment in Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Carbidopa (Carbidopa)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-01-09